RecruitingNot ApplicableNCT06288477

Clinical and Radiographic Evaluation of Vital Pulpotomy Techniques in Primary Molars Using of Premixed Bioactive Bioceramic MTA (Neo-putty) as a Novel Pulpotomy Medication Versus Formocresol

Clinical and Radiographic Evaluation of Vital Pulpotomy Techniques in Primary Molars Using of Premixed Bioactive Bioceramic MTA (Neo-putty) as a Novel Pulpotomy Medication Versus Formocresol: A Randomized Clinical Trial.


Sponsor

October University for Modern Sciences and Arts

Enrollment

44 participants

Start Date

Mar 20, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

Despite the benefit of formocresol, there are toxic effects allergic reactions and local soft and hard tissue necrosis have been reported when such formaldehyde compounds were used clinically, however, the adverse effect of the clinically used of this compound are not widely reported. It has been stated that it has a side effect on the permanent successor although it results as a successful technique for the treatment of the primary teeth


Eligibility

Min Age: 4 YearsMax Age: 9 Years

Inclusion Criteria5

  • Criteria The eligibility criteria were set according to the guidelines of AAPD, 2020. (4)
  • years old
  • Primary molars with no spontaneous or provoked pain
  • Primary molars with at least two-thirds of the root length were still present.
  • Primary molars with no sign of internal or other kinds of root or bone resorption.

Exclusion Criteria3

  • Patients with systemic diseases (congenital or rheumatic heart disease, hepatitis, nephritis, tumor, cyclic neutropenia, leukemia, and children on long-term corticosteroid therapy).
  • Un-cooperative patients.
  • Un-restorable primary molars (Grossly broken-down primary molars that have decay extending way under the gingiva and tooth with root caries).

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGA cotton pellet moistened with full-strength FC

A cotton pellet moistened with full-strength FC will be placed for 5 minutes on the amputated pulp, after reaching hemostasis. The pulp stumps will be then covered by IRM (Intermediate Restorative Material).

DRUGNeo-Putty

Following removal of the coronal pulp with a round bur and hemostasis, the pulp stumps in the study group will be covered with Neo-Putty ® according to the manufacturer's instructions. Neo-Putty will be placed in the prepared cavity, and then covered with a reinforced Zinc Oxide-Eugenol (IRM, Bayer-Leverkussen, Germany).


Locations(1)

MSA University

El-Sheikh Zayed City, Giza Governorate, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06288477


Related Trials